Biochanin-A induces apoptosis and suppresses migration in FaDu human pharynx squamous carcinoma cells
- PMID: 28901495
- DOI: 10.3892/or.2017.5953
Biochanin-A induces apoptosis and suppresses migration in FaDu human pharynx squamous carcinoma cells
Abstract
The aim of the present study was to investigate biochanin-A-induced anticancer effects and their cellular signaling pathway in FaDu pharyngeal squamous carcinoma cells. Biochanin-A induced cell death through increased cytotoxicity of FaDu cells in a dose- and time-dependent manner. The number of cells with nucleus condensation and the apoptotic population were increased in the FaDu cells stimulated with biochanin-A for 24 h. Furthermore, extrinsic apoptotic factors such as FasL and their downstream target caspase-8 were increased and activated in the FaDu cells treated with biochanin-A in a dose-dependent manner. Moreover, biochanin-A decreased the expression of intrinsic anti-apoptotic factors such as Bcl-2 and Bcl-xL, and increased the level and activation of intrinsic apoptotic factors such as Bad and caspase-9. Finally, biochanin-A induced the activation of caspase-3 and Poly(ADP ribose) polymerase (PARP) in FaDu cells. Our results suggest that biochanin-A-induced apoptosis was mediated by death receptor mediated-extrinsic and mitochondria-dependent intrinsic apoptotic signaling pathways. Biochanin-A also inhibited wound healing migration and proliferation of FaDu cells via the downregulation and inactivation of matrix metalloproteinase-2 and -9 that are mediated by the suppression of p38, mitogen activated protein kinase (MAPK), NF-κB and Akt cellular signaling pathways. Therefore, these data suggest that the biochanin-A may act as a potential chemotherapeutic compound to treat head and neck cancer.
Similar articles
-
Berberine-induced anticancer activities in FaDu head and neck squamous cell carcinoma cells.Oncol Rep. 2015 Dec;34(6):3025-34. doi: 10.3892/or.2015.4312. Oncol Rep. 2015. PMID: 26503508
-
Licochalcone-A induces intrinsic and extrinsic apoptosis via ERK1/2 and p38 phosphorylation-mediated TRAIL expression in head and neck squamous carcinoma FaDu cells.Food Chem Toxicol. 2015 Mar;77:34-43. doi: 10.1016/j.fct.2014.12.013. Epub 2015 Jan 5. Food Chem Toxicol. 2015. PMID: 25572524 Free PMC article.
-
Arctigenin induces caspase-dependent apoptosis in FaDu human pharyngeal carcinoma cells.Korean J Physiol Pharmacol. 2022 Nov 1;26(6):447-456. doi: 10.4196/kjpp.2022.26.6.447. Korean J Physiol Pharmacol. 2022. PMID: 36302620 Free PMC article.
-
Investigating the Anticancer Potential of Biochanin A in KB Oral Cancer Cells Through the NFκB Pathway.Cell Biochem Funct. 2024 Sep;42(7):e4130. doi: 10.1002/cbf.4130. Cell Biochem Funct. 2024. PMID: 39364853 Review.
-
Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.Phytother Res. 2024 Feb;38(2):489-506. doi: 10.1002/ptr.8050. Epub 2023 Oct 31. Phytother Res. 2024. PMID: 37905329 Review.
Cited by
-
Capsaicin exerts synergistic pro-apoptotic effects with cisplatin in TSCC through the calpain pathway via TRPV1.J Cancer. 2024 Jul 9;15(15):4801-4817. doi: 10.7150/jca.98075. eCollection 2024. J Cancer. 2024. PMID: 39132151 Free PMC article.
-
The combination of Biochanin A and SB590885 potentiates the inhibition of tumour progression in hepatocellular carcinoma.Cancer Cell Int. 2020 Aug 5;20:371. doi: 10.1186/s12935-020-01463-w. eCollection 2020. Cancer Cell Int. 2020. PMID: 32774165 Free PMC article.
-
Network Pharmacology Integrated Molecular Docking Reveals the Antiosteosarcoma Mechanism of Biochanin A.Evid Based Complement Alternat Med. 2019 Jan 6;2019:1410495. doi: 10.1155/2019/1410495. eCollection 2019. Evid Based Complement Alternat Med. 2019. PMID: 30723510 Free PMC article.
-
Biochanin A Suppresses Tumor Progression and PD-L1 Expression via Inhibiting ZEB1 Expression in Colorectal Cancer.J Oncol. 2022 Feb 22;2022:3224373. doi: 10.1155/2022/3224373. eCollection 2022. J Oncol. 2022. PMID: 35242187 Free PMC article.
-
Chemical and Biological Properties of Biochanin A and Its Pharmaceutical Applications.Pharmaceutics. 2023 Mar 30;15(4):1105. doi: 10.3390/pharmaceutics15041105. Pharmaceutics. 2023. PMID: 37111591 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials